142 related articles for article (PubMed ID: 3106034)
1. Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteers.
Machka K; Milatovic D
Eur J Clin Microbiol; 1987 Feb; 6(1):59-62. PubMed ID: 3106034
[TBL] [Abstract][Full Text] [Related]
2. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of amifloxacin (WIN 49,375) compared with those of ciprofloxacin and ofloxacin.
Digranes A
Acta Pathol Microbiol Immunol Scand B; 1987 Feb; 95(1):29-32. PubMed ID: 3105246
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
Forsgren A
Scand J Infect Dis; 1985; 17(1):91-4. PubMed ID: 3158070
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and serum bactericidal titers of ciprofloxacin and ofloxacin following multiple oral doses in healthy volunteers.
Israel D; Gillum JG; Turik M; Harvey K; Ford J; Dalton H; Towle M; Echols R; Heller AH; Polk R
Antimicrob Agents Chemother; 1993 Oct; 37(10):2193-9. PubMed ID: 8257144
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.
Machka K; Braveny I
Eur J Clin Microbiol; 1987 Aug; 6(4):482-5. PubMed ID: 3117538
[TBL] [Abstract][Full Text] [Related]
7. Bactericidal activity of ciprofloxacin, norfloxacin and ofloxacin in serum and urine after oral administration to healthy volunteers.
Zeiler HJ; Beermann D; Wingender W; Förster D; Schacht P
Infection; 1988; 16 Suppl 1():S19-23. PubMed ID: 3286510
[TBL] [Abstract][Full Text] [Related]
8. Comparative crossover assessment of serum bactericidal activity and pharmacokinetics of ciprofloxacin and ofloxacin.
Echols R; Weinstein MP; O'Keeffe B; Shah A; Heller AH
J Antimicrob Chemother; 1994 Jan; 33(1):111-8. PubMed ID: 8157551
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.
Chau PY; Leung YK; Ng WW
Infection; 1986; 14 Suppl 4():S237-9. PubMed ID: 3469153
[TBL] [Abstract][Full Text] [Related]
10. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of 310 nonfermentative gram-negative bacteria to aztreonam, carumonam, ciprofloxacin, ofloxacin and fleroxacin.
Appelbaum PC; Spangler SK; Tamarree T
Chemotherapy; 1988; 34(1):40-5. PubMed ID: 3127127
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
Chin NX; Figueredo VM; Novelli A; Neu HC
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):58-63. PubMed ID: 3132380
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of newer quinolones against aerobic bacteria.
Auckenthaler R; Michéa-Hamzehpour M; Pechère JC
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
[TBL] [Abstract][Full Text] [Related]
14. North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. A 53-medical-center sample of spectra of activity. North American Ofloxacin Study Group.
Jones RN; Hoban DJ
Diagn Microbiol Infect Dis; 1994 Jan; 18(1):49-56. PubMed ID: 8026157
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives.
Kern W; Gulden H; Vanek E; Kurrle E
Chemotherapy; 1988; 34(2):117-26. PubMed ID: 3164670
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
Digranes A; Dibb WL; Benonisen E
Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
[TBL] [Abstract][Full Text] [Related]
17. Serum bactericidal activity of two newer quinolones against Salmonella typhi compared with standard therapeutic regimens.
Trautmann M; Krause B; Birnbaum D; Wagner J; Lenk V
Eur J Clin Microbiol; 1986 Jun; 5(3):297-302. PubMed ID: 2943588
[TBL] [Abstract][Full Text] [Related]
18. Ofloxacin: in-vitro activity against clinical isolates.
Grima P
Chemioterapia; 1985 Dec; 4(6):434-5. PubMed ID: 3938347
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of ofloxacin and its mode of action.
Sato K; Inoue Y; Fujii T; Aoyama H; Mitsuhashi S
Infection; 1986; 14 Suppl 4():S226-30. PubMed ID: 3028966
[TBL] [Abstract][Full Text] [Related]
20. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
King A; Phillips I
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
